April 2, 2026 | Blog

For sterile injectable programs, lyophilization (freeze-drying) is often the difference between a formulation that is difficult to ship and store and one that can maintain quality over its intended shelf life. BioTechnique® has expanded its aseptic filling & lyophilization services to support pharmaceutical programs from development through commercial supply, with workflows designed to reduce handoffs and support faster timelines.

 

As a full-service Contract Research, Development, and Manufacturing Organization (CRDMO), BioTechnique integrates development and manufacturing activities with quality systems and supporting services, enabling a more connected path from formulation through fill-finish, optional lyophilization, and downstream readiness.

 

Flexible Sterile Formats Supported by End-to-End Aseptic Manufacturing

BioTechnique’s expanded platform supports multiple sterile formats, including vials (2R–100H), prefilled syringes, cartridges, and bags—helping clients select the right presentation for clinical and commercial needs.

 

The aseptic workflow spans core sterile manufacturing steps—formulation, compounding, sterile filtration, filling, stoppering, optional lyophilization, capping, 100% visual inspection, labeling, and packaging—providing a single, coordinated process rather than fragmented vendor transitions.

 

Lyophilization Cycle Development Built for Robust, Inspection-Ready Processes

BioTechnique’s integrated lyophilization expertise includes lyophilization cycle development services covering formulation support, cycle design and optimization, scale-up, validation/QA, and final product testing. This end-to-end focus is intended to strengthen process robustness and protect product integrity across shelf life.

To further strengthen outcomes, BioTechnique’s lyophilization leadership includes collaboration with Dr. Serguei Tchessalov, a globally recognized subject matter expert in freeze-drying science and tech transfer, supporting client programs from early development through commercialization.

 

In-House Quality Laboratory Support (R&D and QC) 

A successful lyophilized product strategy requires timely data for development decisions and batch disposition. BioTechnique’s Quality Laboratory offers a wide array of R&D and QC laboratory testing services using advanced instrumentation.

 

Analytical capabilities include chromatography and spectroscopy tools such as HPLC/UPLC, FTIR, and UV/Vis, along with Karl Fischer moisture testing, TOC analysis, pH and conductivity, osmolality testing, and Differential Scanning Calorimetry (DSC) to support characterization and stability-informed decisions.

 

Microbiology capabilities include endotoxin testing, bioburden analysis, sterility testing in SKAN isolators, and MALDI‑TOF microbial identification for rapid, species-level identification.

 

Real-Time Documentation with ACE® Cloud eQMS

Documentation readiness is central to regulated sterile manufacturing. BioTechnique’s platform is powered by ACE®, its cloud-native electronic Quality Management System (eQMS), supporting controlled documentation, real-time tracking, and data-driven reporting to improve visibility and inspection readiness across the lifecycle.

 

Integrated Storage and 3PL for Cold Chain Continuity

BioTechnique integrates these services with third-party logistics (3PL) and controlled warehousing across ambient (15–25°C), refrigerated (2–8°C), frozen (−20°C), ultra‑low (−80°C), and cryogenic (−190°C) conditions. The platform also supports fully electronic, real-time digital inventory and temperature monitoring (with optional custom access) and GDP-aligned shipping via validated carriers with real-time tracking and documented chain of custody for temperature-sensitive freight.

 

Why Integration Matters for Pharmaceutical and Biotech Teams

When aseptic manufacturing, lyophilization services, QC testing, quality systems, and storage/logistics are aligned under one CRDMO, teams can reduce coordination burden and compress decision cycles. BioTechnique’s integrated model is designed to support development through commercial supply with fewer handoffs, consistent documentation, and a clearer path from fill-finish to storage and distribution readiness.

 

About BioTechnique®  

BioTechnique, a division of PSC Biotech Corporation, is a full-service Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in cytotoxic and therapeutic sterile injectable fill-finish services. BioTechnique provides comprehensive support from investigation and clinical stages through commercialization, batch sizes both large and small.

 

BioTechnique operates a state-of-the-art facility designed to handle a diverse range of pharmaceutical products, including cytotoxic and highly potent compounds, therapeutics, antibody-drug conjugates (ADCs), monoclonal antibodies, suspensions, and vaccines. Supported by an environmentally controlled warehouse and adaptable manufacturing systems, BioTechnique is committed to delivering high-quality fill-finish solutions.

 

Explore more of BioTechnique’s capabilities at https://biotechnique.com/ 

Follow BioTechnique on LinkedIn for more updates and resources: https://www.linkedin.com/company/biotechnique/